To hear about similar clinical trials, please enter your email below

Trial Title: MBC Physical Activity Study

NCT ID: NCT06500858

Condition: Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma

Conditions: Official terms:
Breast Neoplasms

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: N/A

Intervention model: Single Group Assignment

Primary purpose: Supportive Care

Masking: None (Open Label)

Intervention:

Intervention type: Other
Intervention name: Exercise Intervention
Description: Receive a welcome package with exercise equipment
Arm group label: Supportive care (virtual exercise sessions)

Intervention type: Other
Intervention name: Exercise Intervention
Description: Participate in virtual-exercise sessions
Arm group label: Supportive care (virtual exercise sessions)

Intervention type: Other
Intervention name: Exercise Intervention
Description: Receive access to optional drop-in classes
Arm group label: Supportive care (virtual exercise sessions)

Intervention type: Other
Intervention name: Health Promotion and Education
Description: Receive monthly newsletters
Arm group label: Supportive care (virtual exercise sessions)

Intervention type: Other
Intervention name: Internet-Based Intervention
Description: Receive access to online fitness buddy matching program
Arm group label: Supportive care (virtual exercise sessions)

Intervention type: Other
Intervention name: Physical Activity
Description: Participate in a walking program
Arm group label: Supportive care (virtual exercise sessions)

Intervention type: Other
Intervention name: Questionnaire Administration
Description: Ancillary studies
Arm group label: Supportive care (virtual exercise sessions)

Summary: This clinical trial evaluates the impact of a tailored physical activity program on physical activity in patients with breast cancer that has spread from where it first started to other places in the body (metastatic). It has been shown that decreased physical activity contributes to poor performance and quality of life. Evidence has also shown that exercise could improve physical fitness, physical functioning, quality of life, and cancer-related fatigue, however, there is concern that it may not be available to those with physical limitations. The proposed physical activity program offers a comprehensive and individualized assessment for each metastatic breast cancer patient and includes a high quality, tailored exercise home-based program designed by an advanced qualified cancer exercise specialist. A tailored physical activity program may improve physical activity in metastatic breast cancer patients.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Female - Aged 18 and older - Able to read and speak English - Diagnosed with metastatic breast cancer within 60 months of study enrollment - Receiving treatment at the Sidney Kimmel Caner Center (SKCC) in Center City - Performance status Eastern Cooperative Oncology Group (ECOG) 0-2 - Insufficiently inactive defined as answer "no" to screening question "On average, do you engage in at least 75 minutes a week of vigorous activity (like jogging) or at least 150 minutes a week of moderate activity (like a brisk walk)?" - Able to comprehend and sign a written informed consent (no cognitive decline) - Willing to comply with all study procedures and be available for the duration of the study through at least week 2 of 2Unstoppable - Medically cleared by co-investigator or principal investigator (PI) to engage in aerobic and resistance exercise intervention - Access to a smart device and have an active wi-fi connection at home Exclusion Criteria: - Severe or unstable cardiopulmonary, metabolic, or renal disease - Unable to walk safely without physical assistance of another person or assistive device - Any condition that may limit the ability to comply with behavioral and physical recommendations of the virtual exercise program - Pregnancy

Gender: Female

Minimum age: 18 Years

Maximum age: 120 Years

Healthy volunteers: No

Locations:

Facility:
Name: Thomas Jefferson University Hospital

Address:
City: Philadelphia
Zip: 19107
Country: United States

Status: Recruiting

Contact:
Last name: Erin Kelly, DO

Phone: 215-955-4763
Email: erin.kelly2@jefferson.edu

Start date: September 6, 2024

Completion date: October 30, 2025

Lead sponsor:
Agency: Thomas Jefferson University
Agency class: Other

Source: Thomas Jefferson University

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06500858

Login to your account

Did you forget your password?